A Lymphocytic Choriomeningitis Virus Glycoprotein Variant That is Retained in the Endoplasmic Reticulum Efficiently Cross-primes CD8(+) T Cell Responses

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Aug 10

PMID 17686978

Citations 11

Authors

Stefan Freigang

Bruno Eschli

Nicola Harris

Markus Geuking

Katharina Quirin

Sabrina Schrempf

Raphael Zellweger

Jacqueline Weber

Hans Hengartner

Rolf M Zinkernagel

Affiliations

Soon will be listed here.

Abstract

Recent studies indicate that T cell cross-priming preferentially occurs against long-lived, stable proteins. We have studied cross-priming by using the glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV), a protein that normally is not MHC class I cross-presented. This study shows that a C-terminally truncated, noncleavable variant of LCMV-GP led to the accumulation of stable, soluble GP trimers in the endoplasmic reticulum (ER) of the antigen donor cell, and thereby converted LCMV-GP into a potent immunogen for cytotoxic T lymphocyte cross-priming. Immunization of mice with tumor cells expressing an ER-retained LCMV-GP variant cross-primed protective antiviral cytotoxic T lymphocyte responses in vivo at least 10,000-fold better than immunization with cells expressing the cross-presentation-"resistant" wild-type LCMV-GP. Thus the ER is a cellular compartment that can provide antigen for cross-presentation, and modifications affecting stability and subcellular localization of the antigen significantly increase its availability for MHC class I cross-presentation. These findings impinge on vaccine strategies.

Citing Articles

Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.

Byford O, Shaw A, Tse H, Todd E, Alvarez-Rodriguez B, Hewson R J Virol. 2024; 98(3):e0200623.

PMID: 38334330 PMC: 10949467. DOI: 10.1128/jvi.02006-23.

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.

Wang M, Jokinen J, Tretyakova I, Pushko P, Lukashevich I Vaccine. 2017; 36(5):683-690.

PMID: 29287681 PMC: 5806529. DOI: 10.1016/j.vaccine.2017.12.046.

The viral context instructs the redundancy of costimulatory pathways in driving CD8(+) T cell expansion.

Welten S, Redeker A, Franken K, Oduro J, Ossendorp F, Cicin-Sain L Elife. 2015; 4.

PMID: 26263500 PMC: 4558566. DOI: 10.7554/eLife.07486.

CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells.

Bernhard C, Ried C, Kochanek S, Brocker T Proc Natl Acad Sci U S A. 2015; 112(17):5461-6.

PMID: 25922518 PMC: 4418891. DOI: 10.1073/pnas.1423356112.

Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.

Ip P, Boerma A, Walczak M, Oosterhuis K, Haanen J, Schumacher T Gene Ther. 2015; 22(7):560-7.

PMID: 25756550 DOI: 10.1038/gt.2015.24.

References

Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel R . Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989; 342(6249):559-61. DOI: 10.1038/342559a0. View

Heath W, Belz G, Behrens G, Smith C, Forehan S, Parish I . Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev. 2004; 199:9-26. DOI: 10.1111/j.0105-2896.2004.00142.x. View

Houde M, Bertholet S, Gagnon E, Brunet S, Goyette G, Laplante A . Phagosomes are competent organelles for antigen cross-presentation. Nature. 2003; 425(6956):402-6. DOI: 10.1038/nature01912. View

Ohashi P, Oehen S, BUERKI K, Pircher H, Ohashi C, Odermatt B . Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991; 65(2):305-17. DOI: 10.1016/0092-8674(91)90164-t. View

Neijssen J, Herberts C, Drijfhout J, Reits E, Janssen L, Neefjes J . Cross-presentation by intercellular peptide transfer through gap junctions. Nature. 2005; 434(7029):83-8. DOI: 10.1038/nature03290. View

Hammond C, Helenius A . Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. J Cell Biol. 1994; 126(1):41-52. PMC: 2120101. DOI: 10.1083/jcb.126.1.41. View

Lo D, Freedman J, Hesse S, Palmiter R, Brinster R, Sherman L . Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol. 1992; 22(4):1013-22. DOI: 10.1002/eji.1830220421. View

Schroder M, Kaufman R . The mammalian unfolded protein response. Annu Rev Biochem. 2005; 74:739-89. DOI: 10.1146/annurev.biochem.73.011303.074134. View

Guermonprez P, Saveanu L, Kleijmeer M, Davoust J, van Endert P, Amigorena S . ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature. 2003; 425(6956):397-402. DOI: 10.1038/nature01911. View

10.

Buchmeier M . Arenaviruses: protein structure and function. Curr Top Microbiol Immunol. 2002; 262:159-73. DOI: 10.1007/978-3-642-56029-3_7. View

11.

Shen L, Sigal L, Boes M, Rock K . Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity. 2004; 21(2):155-65. DOI: 10.1016/j.immuni.2004.07.004. View

12.

Letarov A, Londer Y, Boudko S, Mesyanzhinov V . The carboxy-terminal domain initiates trimerization of bacteriophage T4 fibritin. Biochemistry (Mosc). 1999; 64(7):817-23. View

13.

Norbury C, Basta S, Donohue K, Tscharke D, Princiotta M, Berglund P . CD8+ T cell cross-priming via transfer of proteasome substrates. Science. 2004; 304(5675):1318-21. DOI: 10.1126/science.1096378. View

14.

Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C . Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001; 7(3):297-303. DOI: 10.1038/85438. View

15.

Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M . Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med. 1999; 189(2):371-80. PMC: 2192989. DOI: 10.1084/jem.189.2.371. View

16.

Touret N, Paroutis P, Terebiznik M, Harrison R, Trombetta S, Pypaert M . Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell. 2005; 123(1):157-70. DOI: 10.1016/j.cell.2005.08.018. View

17.

Wolkers M, Brouwenstijn N, Bakker A, Toebes M, Schumacher T . Antigen bias in T cell cross-priming. Science. 2004; 304(5675):1314-7. DOI: 10.1126/science.1096268. View

18.

Sbalzarini I, Mezzacasa A, Helenius A, Koumoutsakos P . Effects of organelle shape on fluorescence recovery after photobleaching. Biophys J. 2005; 89(3):1482-92. PMC: 1366654. DOI: 10.1529/biophysj.104.057885. View

19.

Binder R, Srivastava P . Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells. Nat Immunol. 2005; 6(6):593-9. DOI: 10.1038/ni1201. View

20.

Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M . Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J Immunol. 2005; 175(2):796-805. DOI: 10.4049/jimmunol.175.2.796. View